Medpace Holdings (01P) Stock Statistics & Valuation Metrics
Total Valuation
Medpace Holdings has a market cap or net worth of EUR 16.13B. The enterprise value is EUR 17.18B.
- Market Cap
- EUR 16.13B
- Enterprise Value
- EUR 17.18B
Share Statistics
Medpace Holdings has 27,971,685 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,971,685
- Owned by Insiders
- 18.66%
- Owned by Institutions
- 53.31%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.98 and return on invested capital (ROIC) is 67.94%.
- Return on Equity (ROE)
- 0.98
- Return on Assets (ROA)
- 0.23
- Return on Invested Capital (ROIC)
- 67.94%
- Return on Capital Employed (ROCE)
- 0.85
- Revenue Per Employee
- 383.37K
- Profits Per Employee
- 68.35K
- Employee Count
- 6,600
- Asset Turnover
- 1.28
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 36.14. Medpace Holdings’s PEG ratio is 1.43.
- PE Ratio
- 36.14
- PS Ratio
- 6.54
- PB Ratio
- 31.69
- Price to FCF
- 27.80
- Price to Operating Cash Flow
- 25.64
- PEG Ratio
- 1.43
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.53B and earned 451.12M in profits. Earnings per share was 15.64.
- Revenue
- 2.53B
- Gross Profit
- 760.62M
- Operating Income
- 534.93M
- Pretax Income
- 542.38M
- Net Income
- 451.12M
- EBITDA
- 570.50M
- Earnings Per Share (EPS)
- 15.64
Cash Flow
In the last 12 months, operating cash flow was 723.05M and capital expenditures -55.42M, giving a free cash flow of 667.63M billion.
- Operating Cash Flow
- 723.05M
- Free Cash Flow
- 667.63M
- Free Cash Flow per Share
- 23.89
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.60%
- Earnings Yield
- 2.79%
Stock Price Statistics
- Beta
- 0.34
- 52-Week Price Change
- 16.57%
- 50-Day Moving Average
- 543.84
- 200-Day Moving Average
- 455.11
- Relative Strength Index (RSI)
- 54.61
- Average Volume (3m)
- 30
Important Dates
Medpace Holdings upcoming earnings date is Feb 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 21, 2026
- Next Earnings Date
- Feb 15, 2027
- Ex-Dividend Date
- ―
Financial Position
Medpace Holdings as a current ratio of 0.74, with Debt / Equity ratio of 29.81%
- Current Ratio
- 0.74
- Quick Ratio
- 0.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.63
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Medpace Holdings has paid 91.25M in taxes.
- Income Tax
- 91.25M
- Effective Tax Rate
- 0.17
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 27.97, with an EV/FCF ratio of 26.96.
- EV to Sales
- 6.34
- EV to EBITDA
- 27.97
- EV to Free Cash Flow
- 26.96
- EV to Operating Cash Flow
- 24.89
Balance Sheet
Medpace Holdings has EUR 705.32M in cash and marketable securities with EUR 146.04M in debt, giving a net cash position of EUR 559.27M billion.
- Cash & Marketable Securities
- EUR 705.32M
- Total Debt
- EUR 146.04M
- Net Cash
- EUR 559.27M
- Net Cash Per Share
- EUR 19.99
- Tangible Book Value Per Share
- -EUR 3.95
Margins
Gross margin is 29.14%, with operating margin of 21.39%, and net profit margin of 18.24%.
- Gross Margin
- 29.14%
- Operating Margin
- 21.39%
- Pretax Margin
- 22.09%
- Net Profit Margin
- 18.24%
- EBITDA Margin
- 22.67%
- EBIT Margin
- 21.70%
Analyst Forecast
The average price target for Medpace Holdings is EUR 600.12, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 600.12
- Price Target Upside
- 0.11% Downside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 9
- Revenue Growth Forecast
- 14.67%
- EPS Growth Forecast
- 18.92%
Scores
- Smart Score
- 4
- AI Score
- ―
